Journal article · 2013

Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead

Xin Ma, Yue Hu

Current Medicinal Chemistry, 20(24), 2991–3010 · Published 1 July 2013 · DOI 10.2174/09298673113209990124

View at the publisherCite this paper

In brief

“Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead” is a 2013 journal article by Xin Ma and Yue Hu, published in Current Medicinal Chemistry. OpenAlex counts 32 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
32
Most cited in
2015 (7)
Field-weighted impact
1.00
Authors
2

Abstract

Nowadays, cancer treatment is moving away from conventional cytotoxic drugs to target-based agents. This is primarily attributed to some remarkable leaps made in deciphering the tumor-relevant signaling pathways. Among them, PI3K/Akt/mTOR cascade presently elicits a substantial amount of pharmaceutical interests owing to its intimate role in tumor initiation and progression. Additionally, its medicinal potential lies… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ma, X., & Hu, Y. (2013). Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead. Current Medicinal Chemistry, 20(24), 2991–3010. https://doi.org/10.2174/09298673113209990124

MLA 9

Ma, Xin, and Yue Hu. “Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead.” Current Medicinal Chemistry, vol. 20, no. 24, 2013, pp. 2991–3010. https://doi.org/10.2174/09298673113209990124.

Chicago

Ma, Xin and Yue Hu. 2013. “Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead.” Current Medicinal Chemistry 20 (24): 2991–3010. https://doi.org/10.2174/09298673113209990124.

Harvard

Ma, X. and Hu, Y. (2013) ‘Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead’, Current Medicinal Chemistry, 20(24), pp. 2991–3010. doi:10.2174/09298673113209990124.

IEEE

X. Ma and Y. Hu, “Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead,” Current Medicinal Chemistry, vol. 20, no. 24, pp. 2991–3010, 2013, doi: 10.2174/09298673113209990124.

BibTeX

@article{ma2013targeting,
  title     = {{Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead}},
  author    = {Ma, Xin and Hu, Yue},
  journal   = {Current Medicinal Chemistry},
  year      = {2013},
  volume    = {20},
  number    = {24},
  pages     = {2991--3010},
  doi       = {10.2174/09298673113209990124},
  url       = {https://doi.org/10.2174/09298673113209990124}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201433
201577
201733
201844
201955
202022
202111
202333
202422
202511

Its field-weighted citation impact is 1.00: it has been cited 1.00 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer

  • PI3K/AKT/mTOR pathway
  • PI3K inhibitors
  • AKT inhibitors
  • mTOR inhibitors
  • kinase inhibitors
  • anticancer drug development
  • kinase specificity
  • pharmacokinetics

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Ma, X., & Hu, Y. (2013). Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead. Current Medicinal Chemistry, 20(24), 2991–3010. https://doi.org/10.2174/09298673113209990124

How many times has this paper been cited?

32 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Xin Ma, Yue Hu.

What is the DOI of this paper?

10.2174/09298673113209990124, permanently at https://doi.org/10.2174/09298673113209990124. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.